Multiple Myeloma and Plasma Cell Neoplasm

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma and Plasma Cell Tumor Trial in United States (arsenic trioxide, dexamethasone)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Tucson, Arizona
  • +9 more
Oct 2, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • oblimersen sodium
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 15, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in United States (bortezomib, pegylated liposomal doxorubicin HCl, vorinostat)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • New York, New York
  • +3 more
Jan 16, 2018

Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in United States (biological, drug, other, procedure)

Terminated
  • Leukemia
  • +5 more
  • anti-thymocyte globulin
  • +11 more
  • Lewes, Delaware
  • +9 more
Feb 6, 2017

Multiple Myeloma and Plasma Cell Tumor Trial in New York (bortezomib, dexamethasone)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 29, 2016

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (omega-3 fatty acid)

Completed
  • Leukemia
  • +2 more
  • omega-3 fatty acid
  • Wilmington, Delaware
  • +4 more
Jul 12, 2016

Multiple Myeloma and Plasma Cell Tumor Trial in New York (bortezomib, dexamethasone, pegylated liposomal doxorubicin HCl)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 16, 2015

Multiple Myeloma and Plasma Cell Tumor Trial in New York (biological, drug, genetic, other)

Terminated
  • Multiple Myeloma and Plasma Cell Neoplasm
  • rituximab
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 19, 2015

Adult Langerhans Cell Histiocytosis, Childhood Langerhans Cell Histiocytosis, Leukemia Trial in New York (Peripheral Blood Stem

Terminated
  • Adult Langerhans Cell Histiocytosis
  • +6 more
  • Peripheral Blood Stem Cell Transplantation
  • New York, New York
    Herbert Irving Comprehensive Cancer Center at Columbia Universit
Jun 5, 2014

Multiple Myeloma and Plasma Cell Tumor Trial in Puerto Rico, South Africa, United States (dexamethasone, pamidronate disodium,

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +77 more
Apr 2, 2014

Multiple Myeloma and Plasma Cell Tumor Trial in San Francisco, New York (bortezomib, melphalan, pegylated liposomal doxorubicin

Unknown status
  • Multiple Myeloma and Plasma Cell Neoplasm
  • San Francisco, California
  • +1 more
Jan 9, 2014

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (biological, drug, procedure)

Unknown status
  • Leukemia
  • +3 more
  • anti-thymocyte globulin
  • +8 more
  • New York, New York
    Herbert Irving Comprehensive Cancer Center at Columbia Universit
Jan 3, 2014

Multiple Myeloma and Plasma Cell Tumor, Precancerous Condition Trial in Atlanta, Rockville, New York (beta alethine)

Unknown status
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Precancerous Condition
  • beta alethine
  • Atlanta, Georgia
  • +2 more
Dec 17, 2013

Childhood Langerhans Cell Histiocytosis, Leukemia, Lymphoma Trial in New York (umbilical cord blood transplantation)

Unknown status
  • Childhood Langerhans Cell Histiocytosis
  • +5 more
  • umbilical cord blood transplantation
  • New York, New York
    Herbert Irving Comprehensive Cancer Center at Columbia Universit
Dec 17, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in Canada, United States (dexamethasone, doxorubicin HCl, valspodar)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • La Jolla, California
  • +39 more
Aug 28, 2013

Anemia, Leukemia, Lymphoma Trial in United States (epoetin alfa, quality-of-life assessment)

Completed
  • Anemia
  • +3 more
  • epoetin alfa
  • quality-of-life assessment
  • Berkeley, California
  • +17 more
Jul 1, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (busulfan, cyclophosphamide, cytarabine)

Completed
  • Leukemia
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 26, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (arsenic trioxide)

Completed
  • Leukemia
  • +2 more
  • arsenic trioxide
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 24, 2013

Leukemia, Lung Cancer, Lymphoma Trial in New York (azacitidine, sodium phenylbutyrate)

Completed
  • Leukemia
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (vorinostat)

Completed
  • Leukemia
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 18, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in New York (filgrastim, melphalan)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (bortezomib)

Completed
  • Leukemia
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Anxiety Disorder, Chronic Myeloproliferative Disorders, Depression Trial in New York (pain therapy, psychosocial assessment and

Completed
  • Anxiety Disorder
  • +6 more
  • pain therapy
  • psychosocial assessment and care
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (pyroxamide)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 4, 2013